Ingevity Corporation (NGVT) Stock Forecast
Data as of May 2, 2026Basic Materials · Current price $76.38 (+0.25%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 2, 2026 | John McNulty | BMO Capital | $83.00 | +8.7% |
| Feb 26, 2026 | Daniel Rizzo | Jefferies | $82.00 | +7.4% |
| Aug 7, 2025 | John McNulty | BMO Capital | $62.00 | -18.8% |
| Oct 31, 2024 | John McNulty | BMO Capital | $47.00 | -38.5% |
| Aug 5, 2024 | John McNulty | BMO Capital | $42.00 | -45.0% |
| Jul 10, 2024 | John McNulty | BMO Capital | $45.00 | -41.1% |
| May 7, 2024 | Chris Kapsch | Loop Capital Markets | $56.00 | -26.7% |
| Apr 22, 2024 | Daniel Rizzo | Jefferies | $62.00 | -18.8% |
| Feb 2, 2023 | Christopher Kapsch | Loop Capital Markets | $100.00 | +30.9% |
Top Analysts Covering NGVT
NGVT vs Sector & Market
| Metric | NGVT | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.80 | 2.36 | 2.41 |
| Analyst Count | 5 | 7 | 18 |
| Target Upside | +0.4% | +54.1% | +14.9% |
| P/E Ratio | -15.97 | -16.54 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.14B | $1.19B | $1.21B | 3 |
| 2027-03-31 | $242M | $248M | $252M | 1 |
| 2027-06-30 | $331M | $339M | $344M | 1 |
| 2027-09-30 | $330M | $338M | $343M | 1 |
| 2027-12-31 | $253M | $260M | $264M | 1 |
| 2028-03-31 | $279M | $286M | $291M | 1 |
| 2028-06-30 | $369M | $378M | $384M | 1 |
| 2028-09-30 | $351M | $360M | $366M | 1 |
| 2028-12-31 | $274M | $280M | $285M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.56 | $4.80 | $4.95 | 2 |
| 2027-03-31 | $1.10 | $1.14 | $1.16 | 1 |
| 2027-06-30 | $1.77 | $1.83 | $1.87 | 1 |
| 2027-09-30 | $1.84 | $1.90 | $1.94 | 1 |
| 2027-12-31 | $1.13 | $1.17 | $1.19 | 1 |
| 2028-03-31 | $1.30 | $1.34 | $1.37 | 1 |
| 2028-06-30 | $2.20 | $2.27 | $2.31 | 1 |
| 2028-09-30 | $2.06 | $2.12 | $2.17 | 1 |
| 2028-12-31 | $1.23 | $1.27 | $1.29 | 1 |
Frequently Asked Questions
What is the analyst consensus for NGVT?
The consensus among 5 analysts covering Ingevity Corporation (NGVT) is Hold with an average price target of $76.67.
What is the highest price target for NGVT?
The highest price target for NGVT is $100.00, set by Christopher Kapsch at Loop Capital Markets on 2023-02-02.
What is the lowest price target for NGVT?
The lowest price target for NGVT is $42.00, set by John McNulty at BMO Capital on 2024-08-05.
How many analysts cover NGVT?
5 analysts have issued ratings for Ingevity Corporation in the past 12 months.
Is NGVT a buy or sell right now?
Based on 5 analyst ratings, NGVT has a consensus rating of Hold (2.80/5) with a +0.4% upside to the consensus target of $76.67.
What are the earnings estimates for NGVT?
Analysts estimate NGVT will report EPS of $4.80 for the period ending 2026-12-31, with revenue estimated at $1.19B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.